S2043 Tumor Mass Reduction Surgery Improves the Prognosis of Enteropathy Associated T Cell Lymphoma

Georgia Malamut(Délégation Paris 5), Christophe Cellier(Assistance Publique – Hôpitaux de Paris), Nadine Cerf–Bensussan(Université Paris Cité), Nicole Brousse(Hôpital Necker-Enfants Malades), Matthieu Allez(Inserm), Olivier Hermine(Centre National de la Recherche Scientifique), Yoram Bouhnik(Clinique Ambroise Paré), Elizabeth Macintyre(Inserm), Raymond Jian(Research Institute of Animal Husbandry), Virginie Verkarre(Université Paris Cité), Anne Berger(Délégation Paris 5), Marie‐Olivia Chandesris(Délégation Paris 5)
Gastroenterology
April 28, 2010
10.1016/s0016-5085(10)61415-1
Cited by 1

Related Papers

Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
|Immunity|2013|4.7k
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936
|Leukemia|2003|3k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
|Journal of Clinical Investigation|2008|1.8k